Silicone Components for Respiratory Circuits: Breathing Tubes, Masks, and Ventilator Accessories — Specification and Compliance Guide

Respiratory circuits are among the most demanding silicone applications in all of medical device manufacturing. Every breath a ventilated patient takes passes through the circuit — and the silicone components that make up that circuit must perform flawlessly across thousands of breath cycles, resist condensate accumulation, maintain dimensional stability under cyclic pressure, and deliver gas that is free of particulates, extractables, and any material that could compromise the respiratory mucosa.

The COVID-19 pandemic exposed the fragility of global respiratory device supply chains and drove unprecedented demand for ventilators, anesthesia machines, and respiratory support equipment. In the years since, respiratory circuit manufacturing has undergone significant quality and regulatory scrutiny — with ISO 18562 (biocompatibility of breathing gas pathways) becoming a mandatory compliance requirement in most major markets, and with clinical awareness of circuit-related complications at an all-time high.

For medical device manufacturers developing respiratory circuit components, OEM product developers specifying silicone for breathing systems, and hospital procurement teams evaluating supplier quality, this guide provides the complete technical and regulatory framework for silicone respiratory circuit components — from corrugated breathing tubes and mask cushions through ventilator accessories, heated wire circuit compatibility, and the specific biocompatibility requirements that distinguish respiratory applications from all other medical silicone uses.

Part 1: The Respiratory Circuit — Anatomy and Silicone's Role

What a Respiratory Circuit Does

A respiratory circuit (also called a breathing circuit or anesthesia breathing system) connects a ventilator or anesthesia machine to a patient's airway, delivering controlled gas mixtures (oxygen, air, anesthetic agents) and removing exhaled carbon dioxide. The circuit must:

• Deliver gas at controlled pressure and flow — without leakage that would cause under-ventilation

• Remove exhaled CO₂ — either by venting to atmosphere (non-rebreathing) or through a CO₂ absorber (rebreathing/circle system)

• Maintain gas temperature and humidity — preventing airway desiccation and hypothermia

• Resist condensate accumulation — water vapor in exhaled gas condenses in the circuit; pooled condensate can cause flow obstruction or patient aspiration

• Withstand cyclic pressure — each breath cycle imposes positive pressure (inspiration) and near-atmospheric pressure (expiration) on the circuit walls

• Be biocompatible with the breathing gas pathway — any extractables or particulates entering the gas stream are inhaled directly into the lungs

Silicone Components in a Standard Respiratory Circuit

Why Silicone Is the Material of Choice for Respiratory Circuits

Part 2: ISO 18562 — The Critical Biocompatibility Standard for Breathing Gas Pathways

Why ISO 18562 Is Different from ISO 10993

ISO 18562 (Biocompatibility evaluation of breathing gas pathways in healthcare applications) is the specific biocompatibility standard for respiratory circuit components. It is fundamentally different from ISO 10993 in one critical respect:

ISO 10993 evaluates the safety of materials in liquid contact with tissue — extractables leach into liquid and contact cells or tissue.

ISO 18562 evaluates the safety of materials in gas contact with the respiratory tract — volatile compounds evaporate from the silicone surface into the breathing gas stream and are inhaled directly into the lungs, bypassing the gastrointestinal absorption and hepatic first-pass metabolism that moderate the toxicity of ingested compounds.

This distinction has profound implications:

• Compounds that are safe at the concentrations found in liquid extractables may be toxic when inhaled at the same concentration

• The inhalation route of exposure has lower tolerance thresholds than oral or parenteral routes for many compounds

• Volatile organic compounds (VOCs) that are below detection limits in liquid extraction may be present at significant concentrations in breathing gas

ISO 18562 Test Series

ISO 18562 consists of four parts, each addressing a different aspect of breathing gas pathway biocompatibility:

ISO 18562-2: Particulate Emissions into Breathing Gas

Particulates in the breathing gas stream are inhaled into the lungs. The standard specifies:

• Test method: Air is passed through the component at defined flow rate and temperature; particles in the effluent air are counted by optical particle counter

• Particle size ranges: ≥0.3μm, ≥0.5μm, ≥1.0μm, ≥5.0μm

• Acceptance criterion: Particle counts must not exceed background levels by more than a defined threshold

• Critical manufacturing implication: Silicone respiratory components must be manufactured in a cleanroom environment with controlled particulate levels — any silicone debris, flash, or manufacturing contamination that enters the breathing gas path is a direct patient safety risk

ISO 18562-3: VOC Emissions into Breathing Gas

This is the most technically demanding part of ISO 18562 for silicone manufacturers. Volatile organic compounds released from silicone surfaces into the breathing gas stream are evaluated against inhalation toxicity limits.

Key VOCs of concern for silicone respiratory components:

Test method: The component is conditioned at 37°C in a sealed chamber with humidified air flowing at clinical breathing flow rates. The effluent air is sampled by Tenax sorbent tubes and analyzed by GC-MS/TD (thermal desorption). Individual VOCs are identified and quantified. Each identified VOC is evaluated against its inhalation OEL (Occupational Exposure Limit) or derived inhalation limit (DIL).

Why platinum-cured silicone is mandatory for respiratory applications:

Peroxide-cured silicone releases acetophenone and benzoic acid — both are volatile compounds that will be detected in ISO 18562-3 testing and will likely exceed inhalation limits at the concentrations present in breathing gas. No peroxide-cured silicone component can pass ISO 18562-3 testing. This is an absolute requirement, not a preference.

For a detailed technical comparison of platinum-cured and peroxide-cured silicone chemistry and why curing system selection matters for patient safety, see: Platinum-Cured vs. Peroxide-Cured Silicone: Which Is Better for Your Application?

ISO 18562-4: Leachables in Condensate

Water vapor in exhaled breath condenses on the inner surfaces of breathing tubes and collects in the circuit. This condensate contacts the silicone surface and can extract leachable compounds. ISO 18562-4 evaluates these condensate leachables.

Test method: The component is exposed to humidified air at 37°C for a defined period. Condensate is collected and analyzed by GC-MS, LC-MS, and ICP-MS for organic leachables and elemental impurities.

Key leachables of concern: Same compounds as ISO 18562-3 (cyclic siloxanes, peroxide by-products) plus elemental impurities (platinum from catalyst, tin if present). Platinum leachables in condensate must be evaluated against ICH Q3D inhalation PDE (1 μg/day).

ISO 18562 vs. ISO 10993 — Which Do You Need?

For a complete guide to biocompatibility certification requirements across all medical silicone applications, see: USP Class VI, ISO 10993, and FDA 21 CFR 177.2600: Which Certification Do You Actually Need?

Part 3: Corrugated Breathing Tubes — The Core Component

Why Corrugated, Not Smooth?

Corrugated (accordion-pleated) wall geometry is the universal design for respiratory circuit breathing tubes. The corrugations serve three critical functions:

1. Kink resistance: The accordion structure allows the tube to bend to acute angles (>90°) without kinking — critical for patient positioning in surgery and ICU. A smooth-walled tube of the same wall thickness would kink at much smaller bend angles.

2. Axial flexibility: Corrugations allow the tube to extend and compress along its length — accommodating patient movement without pulling on the airway connection.

3. Condensate drainage: The corrugation valleys collect condensate, preventing it from pooling in a continuous film that could obstruct flow or be aspirated. Water traps are placed at low points in the circuit to drain collected condensate.

Corrugated Breathing Tube Specification Parameters

ISO 5367 — The Dimensional Standard for Breathing Tubes

ISO 5367 (Breathing tubes intended for use with anaesthetic apparatus and ventilators) specifies:

• Connector dimensions: 22mm male/female ISO taper connectors per ISO 5356-1 — the universal connection standard for adult respiratory circuits

• Leak test: Breathing tubes must withstand 60 cmH₂O internal pressure without leakage

• Kink test: Tubes must maintain ≥50% of nominal ID when bent to a defined radius

• Tensile test: Connectors must withstand defined pull-out force without disconnection

• Particulate cleanliness: Internal surfaces must be free of particulates above defined limits

Kink Resistance — The Critical Performance Parameter

Kink resistance is the most clinically important mechanical property of corrugated breathing tubes. A kinked breathing tube causes complete airway obstruction — a life-threatening emergency in a ventilated patient.

Kink resistance is determined by three factors:

1. Shore A hardness: Firmer compounds (Shore A 50–60) resist kinking better than softer compounds (Shore A 35–45). However, firmer compounds are less comfortable for patients in non-invasive ventilation applications.

2. Wall thickness: Thicker walls resist kinking but reduce flexibility and increase circuit weight (relevant for neonatal and pediatric applications).

3. Corrugation geometry: Deeper corrugations (greater peak-to-valley height) provide better kink resistance. Tighter pitch (more corrugations per unit length) also improves kink resistance.

Kink resistance specification: Per ISO 5367, the tube must maintain ≥50% of nominal ID when bent to a 180° U-shape with a bend radius equal to the tube OD. A more demanding clinical specification is ≥75% ID maintenance at 90° bend — we recommend this as the minimum for ICU ventilator circuits.

Heated Wire Circuit Compatibility

Modern respiratory circuits increasingly incorporate heated wire (HWC) technology — a resistive heating element embedded in the breathing tube wall that warms the gas stream to body temperature, preventing condensate formation and maintaining airway humidity.

Silicone specifications for heated wire circuits have additional requirements beyond standard breathing tubes:

Thermal stability: The heating element operates at 37–42°C continuously. The silicone must maintain its mechanical properties and dimensional stability at these temperatures — platinum-cured silicone is fully stable at these temperatures.

Electrical insulation: The silicone jacket surrounding the heating wire must provide reliable electrical insulation. Dielectric strength of medical-grade platinum-cured silicone: typically 15–25 kV/mm — more than adequate for the low voltages used in HWC systems (typically 12–24V DC).

Wire integration: The heating wire is integrated into the silicone tube wall during extrusion (co-extrusion with wire) or bonded to the outer surface. Co-extrusion requires precise wire tension control and die design to ensure consistent wire position within the wall.

Connector compatibility: HWC circuits use specialized connectors with electrical contacts for the heating wire. Silicone connector seals must accommodate the electrical contact geometry without compromising gas-tight sealing.

Part 4: Anesthesia and Non-Invasive Ventilation Masks — Cushion Design and Specification

The Mask Cushion — Where Silicone Meets Skin

The mask cushion (also called the mask seal or facial interface) is the silicone component that contacts the patient's face and creates the gas-tight seal necessary for effective mask ventilation. It is one of the most demanding silicone design challenges in respiratory medicine — requiring simultaneous optimization of:

• Seal integrity across the full range of facial anatomies

• Patient comfort during prolonged wear (NIV patients may wear masks for 8–20 hours/day)

• Skin biocompatibility — facial skin is sensitive; pressure ulcers from poorly designed masks are a significant clinical problem

• Minimal dead space — the volume of gas trapped between the mask and the face that must be re-breathed

• Durability — reusable masks must withstand repeated autoclave sterilization

Mask Cushion Design Types

Silicone Specification for Mask Cushions

Shore A hardness: Mask cushions require the softest silicone used in any respiratory application — Shore A 5–35 depending on cushion type. The cushion must conform to facial contours under the low clamping forces used in clinical practice (typically 5–15N for NIV masks). Overly firm cushions cause pressure points and skin breakdown.

Skin biocompatibility: The mask cushion is in prolonged contact with facial skin — potentially 8–20 hours/day for home NIV patients. ISO 10993-10 sensitization and irritation testing is mandatory. ISO 18562-3 VOC testing applies to the breathing gas pathway side of the mask. The cushion must pass both standards.

Compression set: Mask cushions undergo repeated compression during use. High compression set causes the cushion to permanently deform, losing its sealing ability over time. Compression set ≤ 15% (ASTM D395, 22h/70°C) is the target for reusable mask cushions.

Autoclave compatibility: Reusable masks must withstand repeated autoclave cycles (134°C, 18 minutes). Platinum-cured silicone is fully compatible with autoclave sterilization — compression set increases slightly with repeated cycling but remains within acceptable limits for 50–100 cycles.

Colorants: Mask cushions are sometimes pigmented (blue, green) for product differentiation. Pigments must be ISO 10993 biocompatibility tested — not all colorants are safe for prolonged skin contact. Inorganic pigments (titanium dioxide, iron oxides) are generally acceptable; organic dyes require individual evaluation.

For a complete guide to sterilization method selection and validation for respiratory silicone components, see: Sterilization Methods for Medical Silicone Products: Autoclave, EtO, Gamma, and E-Beam Compared

Part 5: Reservoir Bags and Anesthesia Bellows

Reservoir Bags — Manual Ventilation and Pressure Relief

The reservoir bag (breathing bag, rebreathing bag) serves two functions in anesthesia breathing systems:

1. Gas reservoir for manual (bag-mask) ventilation — the clinician squeezes the bag to deliver a breath

2. Pressure relief — the bag distends to absorb excess gas pressure, preventing barotrauma

Reservoir bag specification:

Tactile feedback — the underappreciated clinical requirement: Experienced anesthesiologists and respiratory therapists assess lung compliance by feeling the resistance of the reservoir bag during manual ventilation. A bag that is too stiff masks compliance changes; a bag that is too soft provides no feedback. Shore A 20–35 with wall thickness 0.4–0.6mm provides the tactile response range that clinicians expect.

Anesthesia Machine Bellows

Anesthesia workstation ventilators use a bellows mechanism — a collapsible silicone accordion structure that compresses to deliver a breath and expands during expiration. The bellows is the mechanical heart of the anesthesia ventilator.

Bellows specification:

Fatigue life validation: Bellows fatigue life must be validated by cyclic compression testing — typically 5,000,000 cycles at the maximum clinical compression ratio — with leak testing and dimensional measurement at defined intervals. This is analogous to the pump segment fatigue life validation described in our IV infusion components guide.

For the parallel discussion of cyclic fatigue validation for IV pump segments, see: Silicone Components for Infusion and IV Therapy Devices: Compliance Requirements and Supplier Selection

Part 6: Anesthetic Agent Compatibility — A Critical Silicone Requirement

Halogenated volatile anesthetic agents — sevoflurane, desflurane, isoflurane, and enflurane — are present at significant concentrations in anesthesia breathing circuits. These agents are lipophilic solvents that can interact with silicone in two ways:

Absorption into Silicone

Halogenated anesthetics absorb into silicone rubber — the degree of absorption depends on the agent's lipophilicity and the silicone compound's crosslink density.

Clinical implications of anesthetic absorption:

• Induction delay: Anesthetic absorbed into the circuit during induction is not delivered to the patient — higher inspired concentrations are required initially

• Emergence delay: Anesthetic absorbed during the case is released during emergence, prolonging recovery

• Agent waste: Absorbed anesthetic is wasted — relevant for expensive agents like desflurane and sevoflurane

Absorption data for platinum-cured silicone (approximate):

Mitigation: For reusable circuits, pre-use flushing with fresh gas flow for 5 minutes before patient connection reduces absorbed agent from previous cases. Single-use circuits eliminate this concern.

Silicone Degradation by Anesthetic Agents

At clinical concentrations (0.5–8% v/v in carrier gas), halogenated anesthetics do not cause significant degradation of platinum-cured silicone. Dimensional stability, mechanical properties, and extractables profile are maintained after prolonged exposure. This has been validated in multiple published studies and is a key reason silicone is preferred over alternative materials for anesthesia circuits.

Important exception: Some non-silicone elastomers (natural rubber, certain TPEs) are significantly degraded by halogenated anesthetics. If your circuit design includes any non-silicone elastomeric components, verify anesthetic compatibility specifically for those materials.

Part 7: Reusable vs. Single-Use Respiratory Circuits — Silicone Specification Implications

The choice between reusable and single-use respiratory circuits has profound implications for silicone specification, quality requirements, and total cost of ownership.

Reusable Circuits — Silicone Requirements

Reusable respiratory circuits are sterilized between patients and used for multiple cases. Silicone specification must account for:

Autoclave durability: Reusable circuits are typically autoclaved at 134°C. Platinum-cured silicone withstands 100+ autoclave cycles with minimal property change. Validate:

• Shore A hardness change: < 5 units after 100 cycles

• Dimensional change: < 2% after 100 cycles

• Tensile strength retention: > 90% after 100 cycles

• ISO 18562 compliance after 100 cycles (VOC emissions may change with repeated autoclaving)

Cleaning agent compatibility: Hospital cleaning protocols use enzymatic detergents, quaternary ammonium compounds, and peracetic acid. Platinum-cured silicone is compatible with standard hospital cleaning agents at recommended concentrations. Verify compatibility with your specific cleaning protocol.

End-of-life criteria: Define the criteria for retiring a reusable circuit — typically based on cycle count, visual inspection (surface cracking, tackiness, discoloration), and functional testing (leak test, kink test). Document end-of-life criteria in the IFU.

Single-Use Circuits — Silicone Requirements

Single-use respiratory circuits are used for one patient and discarded. Silicone specification focuses on:

Cost optimization: Single-use circuits compete on price — silicone compound selection and manufacturing process must be optimized for cost without compromising ISO 18562 compliance.

Shelf life: Single-use circuits must maintain performance over their labeled shelf life (typically 2–3 years). Accelerated aging validation per ASTM F1980 is required.

EtO sterilization compatibility: Single-use circuits are typically EtO-sterilized. EtO residuals must meet ISO 10993-7 limits for respiratory contact (inhalation route — stricter than other routes):

• EtO: ≤ 0.1 mg/device (inhalation — significantly stricter than the 2 mg/device limit for other routes)

• ECH: ≤ 0.5 mg/device

• EG: ≤ 40 mg/device

The inhalation EtO residual limit (0.1 mg/device) is 20× stricter than the limit for non-inhalation devices (2 mg/device). This requires extended aeration after EtO sterilization — typically 7–14 days at room temperature or 24–48 hours at 50°C. Aeration validation must be conducted specifically for the respiratory circuit configuration.

Part 8: Regulatory Standards Summary for Respiratory Silicone Components

Regulatory Classification

Part 9: OEM Development — Specification Checklist for Respiratory Silicone Components

Use this checklist when approaching silicone suppliers for respiratory circuit component development.

For All Respiratory Silicone Components

• Confirm platinum-cured compound — peroxide-cured is disqualifying for ISO 18562-3

• Request ISO 18562-3 VOC test report (GC-MS/TD) — not just ISO 10993-5

• Request ISO 18562-2 particulate emissions test report

• Confirm ISO Class 7 cleanroom manufacturing

• Confirm post-cure process (200°C, ≥2 hours) for VOC reduction

• Request lot-specific Certificate of Analysis

Additional for Corrugated Breathing Tubes

• Confirm 22mm ISO taper connector dimensions per ISO 5356-1

• Request kink resistance test data (≥75% ID at 90° bend)

• Request leak test data (60 cmH₂O, zero leakage)

• Specify heated wire compatibility if HWC design

• Confirm autoclave cycle durability (100 cycles at 134°C) for reusable circuits

Additional for Mask Cushions

• Specify Shore A hardness (5–35 depending on cushion type)

• Request ISO 10993-10 sensitization and irritation test report

• Request compression set data (≤15% target)

• Confirm colorant biocompatibility if pigmented

• Specify autoclave cycle requirement for reusable masks

Additional for Reservoir Bags and Bellows

• Specify burst pressure requirement (≥60 cmH₂O for bags)

• Request fatigue life data (≥5,000,000 cycles for bellows)

• Specify compliance range (mL/cmH₂O) for reservoir bags

• Confirm anesthetic agent compatibility (sevoflurane, desflurane, isoflurane)

Additional for Single-Use EtO-Sterilized Circuits

• Request EtO residuals test report — confirm ≤0.1 mg/device (inhalation limit)

• Request aeration validation data

• Request shelf life validation data (accelerated aging per ASTM F1980)

For a complete supplier qualification framework including remote audit protocols, see: How to Conduct a Remote Factory Audit of a Chinese Medical Silicone Manufacturer

For supply chain resilience strategies for critical respiratory circuit components, see: Medical Silicone Supply Chain Risk Management: How to Build a Resilient Sourcing Strategy

Chensheng Medical Respiratory Silicone Products

Jinan Chensheng Medical Technology Co., Ltd. manufactures a complete range of silicone respiratory circuit components for global ventilator manufacturers, anesthesia equipment OEMs, and hospital procurement.

All respiratory products manufactured with:

• Platinum-cured silicone — zero peroxide-cured material in respiratory product lines

• ISO Class 7 cleanroom manufacturing

• Post-cure at 200°C (VOC reduction validated)

• ISO 18562 full compliance documentation

• ISO 13485 quality management system

→ Request Respiratory Circuit Samples and Specifications→ Discuss Your Ventilator or Anesthesia OEM Requirements→ Request Our ISO 18562 Compliance Documentation

Frequently Asked Questions (FAQ)

Q1: What is ISO 18562, and why is it different from ISO 10993 for respiratory components?

A: ISO 18562 is the biocompatibility standard specifically for breathing gas pathways — it evaluates the safety of materials that contact the breathing gas stream rather than tissue or liquid. The critical difference from ISO 10993 is the route of exposure: compounds released from respiratory circuit materials are inhaled directly into the lungs, bypassing the gastrointestinal and hepatic processing that moderates the toxicity of ingested compounds. ISO 18562 has four parts: Part 2 evaluates particulate emissions into breathing gas; Part 3 evaluates volatile organic compound (VOC) emissions; Part 4 evaluates leachables in condensate. All four parts are required for breathing tubes, masks, and ventilator circuit components. ISO 10993 alone is not sufficient — a supplier who provides only ISO 10993 documentation for respiratory circuit components has not met the applicable standard.

Q2: Why is the EtO residual limit for respiratory devices 20× stricter than for other medical devices?

A: EtO residual limits are set based on the route of exposure and the resulting patient dose. For non-respiratory devices, EtO residuals contact skin, mucosa, or tissue — absorption is limited and hepatic metabolism reduces systemic exposure. For respiratory devices, EtO residuals in the device are volatilized into the breathing gas stream and inhaled directly into the lungs — pulmonary absorption is highly efficient, and the inhaled dose reaches the systemic circulation without first-pass metabolism. This results in a much higher systemic exposure per unit of residual EtO, requiring the 20× stricter limit (0.1 mg/device vs. 2 mg/device). For single-use respiratory circuits, EtO aeration validation must specifically demonstrate compliance with the 0.1 mg/device inhalation limit — general medical device aeration protocols are not adequate.

Q3: Can the same silicone compound be used for both the breathing tube and the mask cushion?

A: Not typically. Breathing tubes require Shore A 40–55 for kink resistance and pressure integrity. Mask cushions require Shore A 15–35 for facial conformability and patient comfort. Using a single compound for both would require compromising on one or both performance requirements. In practice, respiratory circuit OEMs specify different compounds for different components — the breathing tube uses a firmer compound optimized for corrugation geometry and kink resistance, while the mask cushion uses a softer compound optimized for facial sealing and comfort. Both compounds must independently pass ISO 18562 testing. At Chensheng Medical, we can supply both compounds from the same platinum-cured silicone family with consistent ISO 18562 compliance documentation.

Q4: How many autoclave cycles can a reusable silicone breathing circuit withstand?

A: Well-manufactured platinum-cured silicone breathing circuits withstand 100–150 autoclave cycles (134°C, 18 minutes) with acceptable property retention — Shore A hardness change < 5 units, dimensional change < 2%, tensile strength retention > 85%. However, the practical service life of a reusable circuit is often limited by connector wear, surface contamination accumulation, or visual degradation before the silicone itself fails mechanically. We recommend establishing a maximum cycle count of 100 cycles for clinical use, with end-of-life criteria based on visual inspection (surface cracking, tackiness, connector looseness) at each reprocessing cycle. ISO 18562-3 VOC emissions should be re-verified after accelerated aging equivalent to 100 autoclave cycles — repeated autoclaving can reduce VOC emissions over time as residual volatiles are driven off, but this should be confirmed rather than assumed.

Q5: We are developing a heated wire breathing circuit. What are the specific silicone requirements for the tube jacket?

A: Heated wire circuit tube jackets have four requirements beyond standard breathing tube specification: (1) Thermal stability at 37–42°C continuous — platinum-cured silicone is fully stable at these temperatures with no property change; (2) Electrical insulation — dielectric strength ≥ 15 kV/mm; verify with your specific wall thickness and operating voltage; (3) Wire integration compatibility — if the wire is co-extruded into the wall, the silicone compound must be compatible with the wire insulation material (typically PTFE or FEP) and must not bond to the wire during cure (preventing wire movement for connector attachment); (4) Dimensional precision at the wire location — wire position within the wall must be consistent to ensure reliable electrical contact at the connector. Provide us with your wire specification (diameter, insulation material, operating voltage) and we will confirm compound and process compatibility before tooling development.

Q6: What is the difference between a circle breathing system and a non-rebreathing circuit, and does it affect silicone specification?

A: A circle breathing system (used in anesthesia) recirculates exhaled gas through a CO₂ absorber — the same gas is breathed multiple times, with CO₂ removed and fresh anesthetic/oxygen added. A non-rebreathing circuit (used in ICU ventilation) vents all exhaled gas to atmosphere and delivers fresh gas for each breath. The silicone specification difference is primarily in chemical exposure: circle systems expose the silicone to CO₂ absorbent (soda lime or Baralyme) vapors and their by-products — including compound A (from sevoflurane degradation by soda lime), which is nephrotoxic at high concentrations. Silicone components in circle systems must be verified for chemical resistance to CO₂ absorbent by-products. Non-rebreathing circuits have simpler chemical exposure — primarily the anesthetic agent in carrier gas. For most platinum-cured silicone compounds, both applications are compatible, but verify specifically if your circuit design includes direct contact between silicone and CO₂ absorbent material.

Q7: Our NIV mask cushion is failing ISO 18562-3 VOC testing. What are the likely causes and how do we fix it?

A: ISO 18562-3 failures in silicone mask cushions are almost always caused by one of three issues: (1) Peroxide-cured compound — if the cushion uses peroxide-cured silicone, acetophenone and benzoic acid will exceed inhalation limits; switch to platinum-cured compound immediately; (2) Insufficient post-cure — cyclic siloxanes (D4, D5, D6) exceed limits; increase post-cure temperature to 200°C and duration to 4 hours minimum; validate by GC-MS measurement of D4/D5/D6 before and after post-cure; (3) Mold release agent contamination — hydrocarbon-based mold release agents leave residues that volatilize in ISO 18562-3 testing; switch to a platinum-cured silicone-compatible mold release (silicone-based or water-based) and validate the new release agent independently. If the failure is caused by a compound-specific extractable not in these categories, request GC-MS identification of the failing compound from your testing laboratory — the compound identity will point to the source and corrective action.

Related Articles:

• Platinum-Cured vs. Peroxide-Cured Silicone: Which Is Better for Your Application?

• USP Class VI, ISO 10993, and FDA 21 CFR 177.2600: Which Certification Do You Actually Need?

• Sterilization Methods for Medical Silicone Products: Autoclave, EtO, Gamma, and E-Beam Compared

• Silicone Shore A Hardness Explained: How to Select the Right Durometer for Your Medical Application

• Medical Silicone Extrusion vs. Injection Molding vs. Compression Molding: Which Process Is Right for Your Component?

• Silicone Components for Infusion and IV Therapy Devices: Compliance Requirements and Supplier Selection

• How to Conduct a Remote Factory Audit of a Chinese Medical Silicone Manufacturer

• Medical Silicone Supply Chain Risk Management: How to Build a Resilient Sourcing Strategy

• How to Choose a Reliable Medical Silicone Manufacturer in China